Skip to main content
. 2017 Oct 2;2017:3037876. doi: 10.1155/2017/3037876

Figure 6.

Figure 6

The effects of curcumin administration on the malondialdehyde (MDA) levels in different regions of the brain (a, b, c) and blood (d). The levels of MDA increased after DZP treatment, both in whole brain (a) homogenate and in frontal lobe (b), but without any statistical significance (DZP + CMC versus CUR + CMC, p > 0.05). MDA displayed higher levels in DZP + CMC versus control (p < 0.01) in the hippocampus (c). CUR administration diminished the same parameter in the blood (d) (p < 0.05). Each group consisted of 10 rats. Results are expressed as mean ± SEM. p < 0.05 as compared with control/CUR + CMC; #p < 0.05 as compared with DZP + CMC.